| ||
Pharmexcil to set up warehouse in Africa and Latin America Economic Times AHMEDABAD: Pharmaceuticals Export Promotion Council (Pharmexcil) will soon have warehouses in Africa and Latin America under co-operative marketing model and is in talks with a few pharmaceutical associations in the respective countries. See all stories on this topic » | ||
Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results Sacramento Bee NASHVILLE, Tenn., Nov. 1, 2012 -- /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced third quarter 2012 financial results. See all stories on this topic » | ||
Angiotech Pharmaceuticals Announces Conference Call and Webcast Sacramento Bee Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical ... See all stories on this topic » | ||
Patents appeal board revokes patent on Roche hepatitis drug Economic Times The decision is another setback for large pharmaceutical companies in India, which earlier this year granted the first ever compulsory licence to domestic drugmaker Natco to sell cheap copies of Bayer AG's cancer drug Nexavar. Global drugmakers see ... See all stories on this topic » | ||
Watson Announces Global Generics Management Team Pharmaceutical Processing Watson Pharmaceuticals, Inc. has announced the Global Generics management team, following the announcement of the completion of the acquisition of the Actavis Group for EUR 4.5 billion. The combination creates the world's third largest generic ... See all stories on this topic » | ||
Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the ... Sacramento Bee 2, 2012 -- /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced an invitation to attend the presentation of data from its Phase 3 clinical studies. The presentation will be held on November ... See all stories on this topic » | ||
Catalyst, BioMarin ink strategic collaboration for Firdapse in North America pharmabiz.com Catalyst Pharmaceutical Partners, Inc. and BioMarin Pharmaceutical Inc. have entered into a strategic collaboration for the rights to Firdapse in North America. Firdapse is an orphan product, which has been approved in the European Union (EU) and is ... See all stories on this topic » | ||
Valeant Pharmaceuticals (VRX) Releases Quarterly Earnings Results Jags Report Valeant Pharmaceuticals logo Valeant Pharmaceuticals (NYSE: VRX) released its earnings data on Friday. The company reported $1.15 earnings per share for the quarter, beating the analysts' consensus estimate of $1.13 by $0.02. Valeant ... See all stories on this topic » | ||
| ||
Teva Turns 3Q Loss on Litigation, Other Charges Pharmaceutical Processing Teva Pharmaceutical Industries Ltd. turned a third-quarter loss, as big charges tied to litigation and potential drugs weighed on the pharmaceutical company's performance. But its adjusted earnings topped Wall Street expectations. The Israeli drugmaker ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment